Clinical administration of new antiepileptic drugs: An overview of safety and efficacy

Epilepsia

Volumn 37, Issue SUPPL. 6, 1996, Pages

  Chadwick, David W ^a   Marson, Tony ^a   Kadir, Zakaria ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Anticonvulsants; Clinical trials; Drug interactions; Drug therapy; Drug toxicity; Epilepsy; Gabapentin; Lamotrigine; Tiagabine; Topiramate; Vigabatrin; Zonisamide

Indexed keywords

GABAPENTIN; LAMOTRIGINE; TIAGABINE; TOPIRAMATE; VIGABATRIN; ZONISAMIDE;

ANTICONVULSANT ACTIVITY; ANTICONVULSANT THERAPY; ATAXIA; CLINICAL TRIAL; CONFERENCE PAPER; DEPRESSION; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; EPILEPSY; FATIGUE; HEADACHE; HUMAN; NAUSEA; PRIORITY JOURNAL; SOMNOLENCE; VERTIGO; VISUAL DISORDER;

EID: 0029827521     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1996.tb06035.x     Document Type: Conference Paper

References (39)

1. Marson AG, Chadwick DW. Comparing antiepileptic drugs. Curr Opin Neurol Neurosurg 1996;9:103-6.
2. Marson AG, Chadwick DW. How easy are randomized controlled trials in epilepsy to find on Medline? The sensitivity and precision of two Medline searches. Epilepsia 1996;37:377-80.
3. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1977;35:1-39.
4. Anhut H, Ashman P, Feuerstein TJ, Sauermann W, Saunders M, Schmidt B. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group. Epilepsia 1994;35:795-801.
5. Sivenius J, Kalviainen R, Ylinen A, Riekkinen P. Double blind study of gabapentin in the treatment of partial seizures. Epilepsia 1991;32:539-42.
6. US Gabapentin Study Group No. 5. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. Neurology 1993;43:2292-8.
7. UK Gabapentin Study Group. Gabapentin in partial epilepsy. Lancet 1990;335:1114-7.
8. Matsuo F, Bergen D, Faught E, et al. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. US Lamotrigine Protocol 0.5 Clinical Trial Group. Neurology 1993;43:2284-91.
9. US 16. Data on file, Glaxo-Wellcome.
10. Messenheimer J, Ramsay RE, Willmore LJ, et al. Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial. Epilepsia 1994;35:113-21.
11. Munich UK 18. Data on file, Glaxo-Wellcome.
12. Binnie CD, Debets RM, Engelsman M, et al. Double blind crossover trial of lamotrigine (Lamictal) as add on therapy in intractable epilepsy. Epilepsy Res 1989;4:222-9.
13. Jawad S, Richens A, Goodwin G, Yuen WC. Controlled trial of lamotrigine (Lamictal) for refractory partial seizures. Epilepsia 1989;30:356-63.
14. Loiseau P, Yuen AW, Duche B, Menager T, Arne-Bes MC. A randomised double blind placebo controlled crossover add on trial of lamotrigine in patients with treatment resistant partial seizures. Epilepsy Res 1990;7:136-45.
15. Schapel GJ, Beran RG, Vajda FJ, et al. Double blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures. J Neurol Neurosurg Psychiatry 1993;56:448-53.
16. Smith D, Baker G, Davies G, Dewey M, Chadwick DW. Outcomes of add on treatment with lamotrigine in partial epilepsy. Epilepsia 1993;34:312-22.
17. Denmark UK46. Data on file, Glaxo-Wellcome.
18. TIA-106. Data on file, Novo Nordisk.
19. TIA-107. Data on file, Novo Nordisk.
20. TIA-109. Data on file, Novo Nordisk.
21. Europe Y1. Data on file, Cilag-Jensen.
22. Europe Y2. Data on file, Cilag-Jensen.
23. Europe Y3. Data on file, Cilag-Jensen.
24. US YD. Data on file, Cilag-Jensen.
25. US YE. Data on file, Cilag-Jensen.
26. AUSO1. Data on file, Hersch Merrell Rouselle.
27. Grunewald RA, Thompson PJ, Corcoran R, Corden Z, Jackson GD, Duncan JS. Effects of vigabatrin on partial seizures and cognitive function. J Neurol Neurosurg Psychiatry 1994;57:1057-63.
28. French JA, Mosier M, Walker S, and the Vigabatrin Protocol 024 Investigative Cohort. A double-blind, placebo controlled study of vigabatrin 3 g/day in patients with uncontrolled complex partial seizures. Neurology 1996;46:54-61.
29. Penry JK, Wilder BJ, Rajesh C, et al. Multicenter dose- response study of vigabatrin in adults with focal (partial) epilepsy [Abstract]. Epilepsia 1993;34(suppl 6):67.
30. Schmidt D, Jacob R, Loiseau P, et al. Zonisamide for add on treatment of refractory partial epilepsy: a European double blind trial. Epilepsy Res 1993;15:67-73.
31. Wilder BJ, Ramsay RE, Guterman A. A double-blind multicenter placebo-controlled study of the efficacy and safety of zonisamide in the treatment of complex partial seizures in medically refractory patients. Internal report of the Dianippon Pharmaceutical Co., 1986.
32. Chadwick D, Lieberman DB, Sauermann N, and the Gabapentin in Generalized Seizures Study Group. Gabapentin in generalized seizures (1996). Epilepsy Res (in press).
33. Chiron C, Dumas C, Dulac O, et al. Vigabatrin versus hydrocortisone as first-line monotherapy in infantile spasms due to tuberose sclerosis. Epilepsia 1995;36(suppl 3):S265.
34. Spilker B, Segreti A. Validation of the phenomenon of regression of seizure frequency in epilepsy. Epilepsia 1984;25:443-9.
35. Willmore JL. Depakote adjunctive therapy in the treatment of partial seizures. Epilepsia 1995;36(suppl 3):S66.
36. Brodie MJ, Richens A, Yuen AWC. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345:476-9.
37. Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985;313:145-51.
38. Macdonald RL, Kelly KM. Antiepileptic drug mechanisms of action. Epilepsia 1995;36(suppl 2):S2-12.
39. Commission on Antiepileptic Drugs of the International League Against Epilepsy. Guidelines for antiepileptic drug trials in children. Epilepsia 1994;35:94-100.